Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

od Taskinen, Marja-Riitta, Borén, Jan
Izdano u Curr Atheroscler Rep (2016)

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

od Taskinen, Marja-Riitta, Packard, Chris J., Borén, Jan
Izdano u Curr Atheroscler Rep (2019)

Dietary Fructose and the Metabolic Syndrome

od Taskinen, Marja-Riitta, Packard, Chris J, Borén, Jan
Izdano u Nutrients (2019)

Causes and Consequences of Hypertriglyceridemia

od Packard, Chris J., Boren, Jan, Taskinen, Marja-Riitta
Izdano u Front Endocrinol (Lausanne) (2020)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

od Borén, Jan, Packard, Chris J., Taskinen, Marja-Riitta
Izdano u Front Endocrinol (Lausanne) (2020)

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

od Shuhei, Nakanishi, Söderlund, Sanni, Jauhiainen, Matti, Taskinen, Marja-Riitta
Izdano 2010

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans

od Adiels, Martin, Mardinoglu, Adil, Taskinen, Marja-Riitta, Borén, Jan
Izdano u Front Physiol (2015)

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

od Kahri, Juhani, Soro-Paavonen, Aino, Ehnholm, Christian, Taskinen, Marja-Riitta
Izdano 2006

A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model

od Krengel, Annette, Hauth, Jan, Taskinen, Marja-Riitta, Adiels, Martin, Jirstrand, Mats
Izdano 2013

Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models

od Berglund, Martin, Adiels, Martin, Taskinen, Marja-Riitta, Borén, Jan, Wennberg, Bernt
Izdano u PLoS One (2015)

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

od Forsblom, Carol, Hiukka, Anne, Leinonen, Eeva S., Sundvall, Jouko, Groop, Per-Henrik, Taskinen, Marja-Riitta
Izdano 2010

Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol

od Björnson, Elias, Adiels, Martin, Gummesson, Anders, Taskinen, Marja-Riitta, Burgess, Stephen, Packard, Chris J, Borén, Jan
Izdano u J Am Coll Cardiol (2024)

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized contr...

od Matikainen, Niina, Söderlund, Sanni, Björnson, Elias, Pietiläinen, Kirsi, Hakkarainen, Antti, Lundbom, Nina, Taskinen, Marja‐Riitta, Borén, Jan
Izdano u Diabetes Obes Metab (2018)

Lipoprotein(a) is Markedly More Atherogenic than LDL: An Apolipoprotein B-based Genetic Analysis

od Björnson, Elias, Adiels, Martin, Taskinen, Marja-Riitta, Burgess, Stephen, Chapman, M. John, Packard, Chris J, Borén, Jan
Izdano u J Am Coll Cardiol (2024)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

od Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Izdano 2009

High-resolution population-specific recombination rates and their effect on phasing and genotype imputation

od Hassan, Shabbeer, Surakka, Ida, Taskinen, Marja-Riitta, Salomaa, Veikko, Palotie, Aarno, Wessman, Maija, Tukiainen, Taru, Pirinen, Matti, Palta, Priit, Ripatti, Samuli
Izdano u Eur J Hum Genet (2020)

Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality

od Fredriksson, Jenny, Anevski, Dragi, Almgren, Peter, Sjögren, Marketa, Lyssenko, Valeriya, Carlson, Joyce, Isomaa, Bo, Taskinen, Marja-Riitta, Groop, Leif, Orho-Melander, Marju
Izdano 2007

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol

od Yetukuri, Laxman, Söderlund, Sanni, Koivuniemi, Artturi, Seppänen-Laakso, Tuulikki, Niemelä, Perttu S., Hyvönen, Marja, Taskinen, Marja-Riitta, Vattulainen, Ilpo, Jauhiainen, Matti, Orešič, Matej
Izdano 2010

Cardiac steatosis and left ventricular function in men with metabolic syndrome

od Nyman, Kristofer, Granér, Marit, Pentikäinen, Markku O, Lundbom, Jesper, Hakkarainen, Antti, Sirén, Reijo, Nieminen, Markku S, Taskinen, Marja-Riitta, Lundbom, Nina, Lauerma, Kirsi
Izdano 2013

Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

od Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Izdano 2010